Skip to main content
Fig. 2 | BMC Pharmacology and Toxicology

Fig. 2

From: A population pharmacokinetic model is beneficial in quantifying hair concentrations of ritonavir-boosted atazanavir: a study of HIV-infected Zimbabwean adolescents

Fig. 2

Basic goodness-of-fit plots for the final model for atazanavir 300 mg (a) and ritonavir 100 mg (b). Upper left panel: The observations are plotted versus the population predictions. Upper right panel: The observations are plotted against the individual predictions. Lower left panel: The individually weighted residuals are plotted versus the individual predictions. Lower right panel: The conditional weighted residuals are shown versus time (in hours). The open black circles represents observed data. The bold-dashed line is a locally weighted scatter-plot smoother (LOESS), while the solid line is identity or zero

Back to article page